To Evaluate the Efficacy of Mobile Applications in Tailoring and Enhancing Rehabilitation Interventions for Pediatric CP

Superior University

Status: Active, not recruiting

Conditions: Cerebral Palsy

Treatments: Device: Mobile Application

Study type: Interventional

Funder types: Other

Identifiers

NCT06428552

MSRSW/Batch-Fall22/712

Details and patient eligibility

About

The world of technology is changing and becoming more advanced. Children with cerebral palsy can benefit from the technology to enhance their mobility, balance, and coordination through mobile applications. A lot of applications are made to offer games and interactive therapy activities that focus on balance, coordination, and motor skills.

Full description

They may find these activities entertaining as well as helpful, which makes their rehabilitation more pleasurable. This work builds on previous studies by making a mobile application that may be accessed from any location, giving therapeutic treatments more distribution flexibility. This is especially helpful for those with cerebral palsy who might have mobility issues that make it challenging to consistently attend in-person therapy sessions. Cerebral palsy children can perform organized exercises at home with the help of mobile application made for therapeutic activities and rehabilitation. Therapeutic activities may be customized to meet the unique demands of each patient, guaranteeing that the treatment plan is in line with their capabilities and objectives. Caregiver's involvement in the treatment process is a common element of app created specifically for people with cerebral palsy. This might involve providing tools to enhance home-based care, educating caregivers through resources, and monitoring progress in order to promote a team-based approach to treatment.

Enrollment: 96 patients

Sex: All

Ages: 5 to 16 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children with cerebral palsy
• Children aged between 5 to 16 years

Exclusion criteria

• Children with unstable epilepsy, chronic heart abnormalities , asthma , anemia and other medical conditions
• undergone botulinum neurotoxin A (BoNT-A)injections or surgery in the previous 2 months or 6 months respectively. "

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

96 participants in 1 patient group

Usual care at home for 12 weeks

Experimental group

Description:

Daily rehabilitation program of 40 minutes duration using a mobile application to be completed 6 days per week for 12 weeks

Treatment:

Device: Mobile Application